Pacific Center for Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Pacific Center for Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72K	Hold	30	–	–	﹤0.01%	438
2026 Q1	$1.7K	Hold	30	–	–	﹤0.01%	444
2025 Q4	$1.63K	Hold	30	–	–	﹤0.01%	422
2025 Q3	$1.63K	Hold	30	–	–	﹤0.01%	422
2025 Q2	$1.65K	Hold	30	–	–	﹤0.01%	406
2025 Q1	$2.12K	Hold	30	–	–	﹤0.01%	406
2024 Q4	$1.97K	Hold	30	–	–	﹤0.01%	411
2024 Q3	$2.11K	Hold	30	–	–	﹤0.01%	403
2024 Q2	$2.47K	Hold	30	–	–	﹤0.01%	395
2024 Q1	$2.62K	Hold	30	–	–	﹤0.01%	398
2023 Q4	$2.89K	Hold	30	–	–	﹤0.01%	334
2023 Q3	$2.65K	Hold	30	–	–	﹤0.01%	351
2023 Q2	$2.6K	Hold	30	–	–	﹤0.01%	342
2023 Q1	$2.92K	Buy	+30	New	+$3.11K	﹤0.01%	339

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Pacific Center for Financial Services's BMRN Position: Q2 2026 in Review

Pacific Center for Financial Services held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 30 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #438.

Pacific Center for Financial Services first reported a position in BMRN in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.92K in Q1 2023. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Pacific Center for Financial Services held 30 shares of BioMarin Pharmaceuticals worth $1.72K as of Q2 2026.
Pacific Center for Financial Services left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #438 holding.
Pacific Center for Financial Services first reported a position in BioMarin Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
Pacific Center for Financial Services's BioMarin Pharmaceuticals position peaked at $2.92K in Q1 2023.
564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.